Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost
- PMID: 16458074
- DOI: 10.1016/j.clim.2005.12.007
Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost
Abstract
Recombinant vaccinia virus-based vaccine combined with DNA vaccine has produced a protective immune response against HIV infection in non-human primates. In this study, we explored the immunogenicity of a recombinant vaccinia virus (LC16m8 strain), which has been used in children without severe side effects. The vaccinia virus expressing an HIV(89.6)env gene (vLC-Env) alone or combined with a DNA vaccine expressing the HIV(89.6)env gene (pCAG-Env) was characterized in BALB/c mice. Vaccination of vLC-Env induced much higher HIV-specific humoral and cell-mediated immune responses than that of pCAG-Env. Priming with pCAG-Env further enhanced vLC-Env induced immune responses, especially cell-mediated immune response. Moreover, efficient expression of Env protein was achieved following infection of bone marrow dendritic cells by vLC-Env in vitro. Administration of vLC-Env-infected dendritic cells to mice generated a high cell-mediated immune response. These results demonstrate that priming with pCAG-Env and boosting with vLC-Env represents a logical candidate for vaccination against HIV infection.
Similar articles
-
Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.Virus Res. 2006 Mar;116(1-2):11-20. doi: 10.1016/j.virusres.2005.08.008. Epub 2005 Oct 7. Virus Res. 2006. PMID: 16214252
-
Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.Virus Res. 2004 Sep 15;105(1):11-22. doi: 10.1016/j.virusres.2004.04.008. Virus Res. 2004. PMID: 15325077
-
Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.Virology. 2000 Feb 1;267(1):8-16. doi: 10.1006/viro.1999.0093. Virology. 2000. PMID: 10648178
-
Prime-boost strategies in DNA vaccines.Methods Mol Med. 2006;127:171-97. doi: 10.1385/1-59745-168-1:171. Methods Mol Med. 2006. PMID: 16988455 Review.
-
Technology evaluation: HIVAC-1e.Curr Opin Mol Ther. 1999 Feb;1(1):121-5. Curr Opin Mol Ther. 1999. PMID: 11249677 Review.
Cited by
-
The evolution of poxvirus vaccines.Viruses. 2015 Apr 7;7(4):1726-803. doi: 10.3390/v7041726. Viruses. 2015. PMID: 25853483 Free PMC article. Review.
-
Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice.Virol J. 2011 Jan 5;8:3. doi: 10.1186/1743-422X-8-3. Virol J. 2011. PMID: 21205330 Free PMC article.
-
Characterization of Rare Spontaneous Human Immunodeficiency Virus Viral Controllers Attending a National United Kingdom Clinical Service Using a Combination of Serology and Molecular Diagnostic Assays.Open Forum Infect Dis. 2023 Mar 1;10(5):ofad108. doi: 10.1093/ofid/ofad108. eCollection 2023 May. Open Forum Infect Dis. 2023. PMID: 37152187 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
